Latest News, Updates & Breaking Headlines
Morgan Stanley maintained equal-weight on Dr Reddy’s Labs with the target price at Rs 1,215 (against Rs 1,259 earlier). Analysts said the company’s Jan-March (Q4FY26) adjusted revenue and earnings before interest, taxes, depreciation, and amortisation (EBITDA) missed estimates by 2% and 13% respectively. Semaglutide ramp-up slightly delayed due to Brazil approval delay. The management expects…
Nuvama has downgraded UPL to hold with the target price at Rs 816. Analysts said the company recently announced a restructuring to create a unified crop protection entity by merging UPL SAS and UPL Corp, which would be listed as UPL Global while UPL Ltd shall stay as the holding company for formulation business, R&D,…
CLSA has downgraded Dixon Technologies to hold from outperform with the target price cut to Rs 12,100 from Rs 15,800 earlier. Analysts said the memory industry is entering a super cycle, driven by AI’s appetite for high-bandwidth memory (HBM) and DDR5, while mainstream storage faces tightening supply and rising costs. India’s dependence on imports leaves…
